Daniel Laverick, VP, Head of the Digital and Data Solutions at Zuellig Pharma, tells us about innovations in blockchain technology and working with MSD.
Zuellig Pharma was founded 100 years ago and has grown to become one of the largest healthcare service provider groups in Asia, valued at US$13 billion. Key products include the online ordering portal eZRx; the eZTracker solution which uses blockchain-based technology to drive transparency and visibility in the supply chain for product authentication; and eZVax, a solution that provides governments, local health authorities and the private sector with end-to-end vaccine management. The latter is primarily used for the COVID-19 vaccine currently, but Laverick says the plan is for this to be used for any vaccine in the future.
Zuellig Pharma’s partnership with pharmaceutical company MSD began in 2020 when eZTracker was deployed in Hong Kong to enhance the traceability of Gardasil®9, MSD’s HPV vaccine. Laverick explains how eZTracker works: “As the vaccines move through various handover points in the supply chain, the products’ data points are loaded into eZTracker’s secure blockchain ledger, and this ensures it can’t be tampered with. Users such as healthcare professionals and patients are able to verify the authenticity of the vaccine by scanning a unique data matrix code on the product pack.”
Collaboration between the two companies has grown since then. “We work closely with MSD’s Connected Channel globally, as well as the regional teams, on expanding the use and outreach of eZTracker” Laverick says. “It really is to support the initiative that MSD has, to go from plant to patient and track and trace its product and material movements.”
Read the full article on Supply Chain Digital.
